Ferroptosis in Arthritis: Driver of the Disease or Therapeutic Option?

被引:0
|
作者
Bieri, Shania [1 ]
Moller, Burkhard [2 ]
Amsler, Jennifer [2 ,3 ]
机构
[1] Univ Bern, Fac Med, CH-3012 Bern, Switzerland
[2] Univ Bern, Bern Univ Hosp, Dept Rheumatol & Immunol, CH-3010 Bern, Switzerland
[3] Univ Bern, Dept Biomed Res DBMR, CH-3008 Bern, Switzerland
关键词
ferroptosis; ROS; lipid peroxidation; iron; rheumatoid arthritis; osteoarthritis; RA-FLS; chondrocytes; RHEUMATOID-ARTHRITIS; CHONDROCYTE FERROPTOSIS; SYNOVIAL FIBROBLASTS; CELL-DEATH; SPONDYLOARTHRITIS; OSTEOARTHRITIS; MECHANISMS; CYTOKINES; CARTILAGE; STRESS;
D O I
10.3390/ijms25158212
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ferroptosis is a form of iron-dependent regulated cell death caused by the accumulation of lipid peroxides. In this review, we summarize research on the impact of ferroptosis on disease models and isolated cells in various types of arthritis. While most studies have focused on rheumatoid arthritis (RA) and osteoarthritis (OA), there is limited research on spondylarthritis and crystal arthropathies. The effects of inducing or inhibiting ferroptosis on the disease strongly depend on the studied cell type. In the search for new therapeutic targets, inhibiting ferroptosis in chondrocytes might have promising effects for any type of arthritis. On the other hand, ferroptosis induction may also lead to a desired decrease of synovial fibroblasts in RA. Thus, ferroptosis research must consider the cell-type-specific effects on arthritis. Further investigation is needed to clarify these complexities.
引用
收藏
页数:29
相关论文
共 50 条
  • [21] Therapeutic inhibition of ferroptosis in neurodegenerative disease
    Ryan, Sean K.
    Ugalde, Cathryn L.
    Rolland, Anne-Sophie
    Skidmore, John
    Devos, David
    Hammond, Timothy R.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2023, 44 (10) : 674 - 688
  • [22] Ferroptosis: An emerging therapeutic target in stroke
    Liu, Yibo
    Fang, Yuanjian
    Zhang, Zeyu
    Luo, Yujie
    Zhang, Anke
    Lenahan, Cameron
    Chen, Sheng
    JOURNAL OF NEUROCHEMISTRY, 2022, 160 (01) : 64 - 73
  • [23] Iron Metabolism and Ferroptosis in Diabetic Kidney Disease
    Mu, Fangxin
    Luo, Ping
    Zhu, Yuexin
    Nie, Ping
    Li, Bing
    Bai, Xue
    CELL BIOCHEMISTRY AND FUNCTION, 2025, 43 (04)
  • [24] Emerging regulatory mechanisms in cardiovascular disease: Ferroptosis
    Jin, Sijie
    Wang, He
    Zhang, Xiaohao
    Song, Mengyang
    Liu, Bin
    Sun, Wei
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 174
  • [25] Molecular Mechanisms of Ferroptosis and Relevance to Cardiovascular Disease
    Xie, Lai-Hua
    Fefelova, Nadezhda
    Pamarthi, Sri Harika
    Gwathmey, Judith K.
    CELLS, 2022, 11 (17)
  • [26] Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology
    Yu, Zongchao
    Mo, Zhongcheng
    Qiu, Yuan
    Lu, Hengzhe
    Zheng, Biao
    Liu, Longfei
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024, 25 (15) : 2012 - 2021
  • [27] The emerging roles of ferroptosis in organ fibrosis and its potential therapeutic effect
    Huang, Xuege
    Song, Yahui
    Wei, Lin
    Guo, Jing
    Xu, Wei
    Li, Min
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 116
  • [28] Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications
    Wu, Zhili
    Zhu, Yanru
    Liu, Wenchao
    Balasubramanian, Balamuralikrishnan
    Xu, Xiao
    Yao, Junhu
    Lei, Xinjian
    ANTIOXIDANTS, 2024, 13 (03)
  • [29] Ferroptosis: a novel pathogenesis and therapeutic strategies for Parkinson disease: A review
    Jiao, Di
    Yang, Yang
    Wang, Kejing
    Wang, Yaomei
    MEDICINE, 2025, 104 (03) : e41218
  • [30] Ferroptosis in Neurological Disease
    David, Samuel
    Ryan, Fari
    Jhelum, Priya
    Kroner, Antje
    NEUROSCIENTIST, 2023, 29 (05) : 591 - 615